Trial no.:
|
PACTR202201742377791 |
Date of Approval:
|
21/01/2022 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
A COMPARISON OF OXYTOCIN -MISOPROSTOL COMBINATION AND CARBETOCIN IN REDUCING BLOOD LOSS AT CAESAREAN SECTION: A RANDOMISED CONTROLLED STUDY
|
Official scientific title |
A comparison of oxytocin -misoprostol combination and carbetocin in reducing blood loss at caesarean section: a randomised controlled study
|
Brief summary describing the background
and objectives of the trial
|
Obstetric haemorrhage still accounts for an estimated 25% of global maternal deaths despite considerable scientific advances made at discerning its causation, prevention and effective treatment. Caesarean section is a common obstetric procedure performed worldwide and haemorrhage at Caesarean section is a significant contributor to the burden of obstetric haemorrhage in sub-Saharan Africa Several efforts have been made for reducing blood loss at Caesarean section among which is the use of oxytocic to improve uterine contractility. Despite all of these interventions, haemorrhage is still a major concern. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Pregnancy and Childbirth |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Education /Training |
Anticipated trial start date |
05/07/2021 |
Actual trial start date |
|
Anticipated date of last follow up |
31/08/2021 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
160 |
Actual target sample size (number of participants) |
|
Recruitment status |
Completed |
Publication URL |
|
|